Stellate Ganglion Block to Augment Trauma-focused Therapy Among Veterans With PTSD
Status:
Not yet recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
Our long-term goal is to improve clinical outcomes among patients receiving psychological
treatment for posttraumatic stress disorder (PTSD). The primary objective of this project is
to examine if stellate ganglion block (SGB) improves outcomes among military personnel and
veterans receiving cognitive processing therapy (CPT), an empirically-supported psychological
treatment for PTSD. To accomplish this objective, we will enroll adult military personnel and
veterans with a current diagnosis of PTSD and/or subthreshold PTSD, provide CPT sessions over
two weeks, administer SGB during or after CPT, and repeatedly assess key outcomes during
follow-up.